Editor, In eyes with uveitic macular oedema, the reproducibility of retinal thickness measurements is an essential parameter to monitor the progression of the disease and/or the therapeutic results. To date, there are no reports concerning reproducibility of optical coherence tomography (OCT) in this type of oedema. The aim of the present study is to value the intraobserver reproducibility of macular thickness measurements performed with Spectralis OCT (Heidelberg Engineering, Heidelberg, Germany) in inflammatory macular oedema. Thirty-three eyes of 33 consecutive patients, 15 men and 18 women, mean age 35.09 ± 16.64 years (range: 7–77) with uveitis and concurrent macular oedema were included in the study. All patients underwent three consecutive OCT examinations with Spectralis OCT performed by the same operator within one session. For retinal thickness measurements, 20 × 15 degree raster scans were taken consisting of 37 high-resolution line scans. The foveolar centre-point retinal thickness (CPT) and the Early Treatment of Diabetic Retinopathy Study (ETDRS) 9 region map were used for quantitative evaluation. The coefficient of repeatability (CR) was calculated according to Bland & Altman (1996). Also, coefficient of variation (COV) was obtained (Menke et al. 2009a,b). For the statistical analysis, Student’s t-test and Kendall’s τ correlation coefficient were used. p-value <0.05 was considered statistically significant. The results are summarized in Table 1. No significant correlation between thickness and CR and between thickness and COV was found (Kendall’s τ correlation coefficients = 0.022, −0.244; p = 0.29, 0.32). Our highest CR and COV were in the foveolar CPT. One reason we can suggest for this result is that the retinal thickening and the presence of most cysts in central area may affect the device measurement process and can slightly degrade the precision of the reproducibility. Also, we think that highest CR and COV in central area may be caused by a reduced fixation ability of patient owing to macular oedema. Nevertheless for the clinical practice, our findings show in any case an excellent index of reproducibility. This evidence is supported by the data reporting no significant difference between the measurements of CPT. The reproducibility can vary according to different OCT models. In eyes with diabetic macular oedema, Polito et al. (2005) reported a COV ranged from 4.84% to 8.33% using stratus OCT 3 (Carl Zeiss Meditec Inc., Dublin, CA, USA). Recently, some studies have reported high reproducibility of the new OCT generation in healthy eyes and in eyes with age-related macular degeneration (Menke et al. 2009a,b). There are not too many studies that compared reproducibility between different OCT types to make a firm statement about the “most reproducible” instrument. Wolf-Schnurrbusch et al. (2009) compared the intersession reproducibility of different commercially available OCT instruments concluding that Spectralis OCT showed the lowest COV (0.46%). The excellent reproducibility with Spectralis OCT is attributable to some technical features such as image speed, greater resolution and retinal segmentation algorithms, which increase the examination performance. However, the most important factor determining the high reproducibility is the eye-tracking mechanism that permits to scan the same scanning location on following visits. In inflammatory macular oedema, an excellent reproducibility permits to consider even any minimal thickness change as a real effect of the therapy and not as a consequence of a measurement error. As far as we know, this is the first study on the reproducibility of retinal thickness measurements in uveitic macular oedema using Spectralis OCT. As we did not study the reproducibility of the OCT performed by different operators, further studies will be needed to test the interobserver reproducibility in such a disease.